Actinium Pharmaceuticals, Inc. Email Format
Biotechnology ResearchUnited States51-200 Employees
Actinium Pharmaceuticals (NYSE: ATNM) is focused on developing innovative targeted radioimmunotherapies for the treatment of advanced cancers. Currently Investigating therapies in #AML and #BMT